Research and Patient Advocacy Take Center Stage at AACR

The Gastric Cancer Foundation promoted its role in advancing early-stage research and patient advocacy at one of the biggest cancer conferences of the year, the American Association for Cancer Research 2026 Annual Meeting, held earlier this month in San Diego. The theme of this year’s meeting was “Precision, Partnership, Purpose: Advancing Cancer Science to Save Lives Globally.”

The foundation, represented by Executive Director Harriet Patterson, MPH, was among 20 groups featured in an Advocates Poster Session during the AACR conference. The poster highlighted our impact in accelerating research and supporting patients, including creating the Gastric Cancer Registry at Stanford University, funding seed grants and offering an online clinical trial finder and patient-support community. Board member Hans Rueffert, our patient advocate and “chef without a stomach,” also represented the foundation at the conference hosting GCF’s booth in the Patient Advocacy Pavillion where he connected with researchers, clinicians, pharma companies, other patient advocates and more.


The Gastric Cancer Registry was featured prominently at the AACR conference, with two studies co-authored by Stanford professor and the registry’s primary investigator, Hanlee Ji, MD. In one study, a Stanford University team used registry data to identify three genes that may raise the risk of stomach lesions progressing to gastric cancer. In the second study, researchers analyzed sequencing data, as well as spacial transcriptomics and proteomics data from more than 200 stomach tumor samples that are housed in public and in-house resources, including the registry. 


Foundation board member Ajay Goel, PhD, of City of Hope, was also featured prominently at the AACR conference, co-chairing a symposium on advances in liquid biopsy technology. “Liquid biopsy technology could be revolutionary not just for predicting cancer before symptoms appear, but also for improving how patients are treated after diagnosis and for preventing recurrence,” Dr. Goel said after the symposium. “There is a lot of exciting research now looking at monitoring immune cells and other types of cells along with liquid biopsies, which could help oncologists adjust treatments based on the likelihood of recurrence. It’s very exciting—these diagnostics could play a big part in improving precision approaches in gastric cancer.”


All in all, the AACR conference marked a valuable opportunity to not only highlight the work of the Gastric Cancer Foundation, but also to connect with our partners and learn about exciting emerging science that promises to improve the lives of the patients we serve.

 

GCF Executive Director Represents Stomach Cancer Community at AACR

Gastric Cancer Foundation Executive Director, Harriet Patterson, MPH, was selected to participate in the 2026 Scientist↔Survivor Program® at the American Association for Cancer Research annual meeting. This invitation-only cohort includes survivors and patient advocates from around the world representing all type of cancer. Patterson represented the gastric cancer community.  


The patient advocates spent five days learning from one another and from leading cancer research experts in fields of immunology, precision medicine, clinical trial design, genetics and more. Patients and advocates also shared their work with more than 23,000 conference attendees in a special Advocates Poster Session. Patterson’s poster highlighted the impact of the Gastric Cancer Foundation in accelerating research through the Gastric Cancer Registry, early-stage research funding, and the Research Scholar initiative, as well as through its clinical trial finder and other patient resources. 


“Participating in the Scientist↔Survivor Program® was inspiring and educational,” Patterson said. “I learned so much about the current state of cancer research from researchers around the world and heard exciting updates about gastric cancer.” Patterson also had the chance to connect with other advocates and the research community to discuss the challenges facing cancer researchers, including funding and policy shifts, complex data arising from precision medicine, and the growing role of AI.


“I came away even more convinced of the critical role Gastric Cancer Foundation can play in advancing research and of the importance of collaboration to foster our continued progress in the fight against stomach cancer,” she said. “None of this progress is possible without GCF’s donors and supporters, so thank you!”

 
 

Your experience matters. Join the registry to help accelerate progress gastric cancer research.

 

A new original video is coming soon! GCF Board Member and 20+ year gastric cancer survivor Hans Rueffert is out and about filming the next episode of the Your New Normal video series. He sat down in Houston with Dr. Shanda Haley Blackmon, MD, MPH from Baylor College of Medicine and interviewed Jonah Middleton, RN to speak with each about how to manage fatigue during and after treatment. This is one you won't want to miss.


Your New Normal is an original video series that addresses the profound impact of gastric cancer on emotional well-being, relationships, work, finances and overall quality of life. Catch up on episodes and follow us on YouTube for more original video resources for patients and caregivers.

 

Quick Links to Resources

 
 
Special Thanks to Our
National Sustaining Sponsors
 
Facebook  Twitter  Linkedin  Youtube  
Spread the word. Share the Gastric Cancer Foundation Newsletter.
X Share This Email
LinkedIn Share This Email